WRBY Warby Parker Inc.

8-K Current Report

Filed: February 26, 2026

Health Care

Ophthalmic Goods

Warby Parker Inc. (WRBY) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q1 2025 earnings press release filed as exhibit — refer to Exhibit 99.1 for full financial results and key metrics
• Reg FD safe harbor language indicates results are disclosed but not incorporated by reference into other SEC filings

Item 8.01 · Other Events

• Board authorized up to $100M share repurchase program for Class A common stock, announced Feb 26, 2026
• No fixed expiration date and no minimum purchase obligation — program can be modified, suspended, or terminated at any time

+2 more insights

Get deeper insights on Warby Parker Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.